Skip to Content

albuterol

Pronunciation

Generic Name: albuterol (oral) (al BYOO teh rall)
Brand Name: Proventil, VoSpire ER

What is albuterol?

Albuterol is a bronchodilator that relaxes muscles in the airways and increases air flow to the lungs.

Albuterol is used to treat bronchospasm (wheezing, shortness of breath) caused by reversible obstructive airway disease in adults and children who are at least 6 years old.

Albuterol may also be used for purposes not listed in this medication guide.

What is the most important information I should know about albuterol?

You should not use albuterol if you are allergic to it.

Before you take albuterol, tell your doctor if you have heart disease, high blood pressure, a heart rhythm disorder, seizures, diabetes, or overactive thyroid.

Tell your doctor if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days.

Do not take albuterol in larger amounts than recommended by your doctor. An overdose of albuterol can be fatal.

Albuterol can have long-lasting effects (up to 8 hours or longer). Do not take this medication more often than prescribed.

Call your doctor right away if you feel that this medicine is not working as well as usual, or if it makes your condition worse. If it seems like you need to use more of any of your medications in a 24-hour period, talk with your doctor.

Breathing disorders are sometimes treated with a combination of drugs. Use all medications as directed by your doctor. Read the medication guide or patient instructions provided with each medication. Do not change your doses or medication schedule without your doctor's advice. You should remain under the care of a doctor while you are using albuterol.

What should I discuss with my healthcare provider before taking albuterol?

You should not use albuterol if you are allergic to it.

To make sure you can safely take albuterol, tell your doctor if you have any of these other conditions:

  • heart disease, high blood pressure;

  • a heart rhythm disorder;

  • epilepsy or other seizure disorder;

  • diabetes; or

  • overactive thyroid.

Tell your doctor if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days.

FDA pregnancy category C. It is not known whether albuterol will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.

It is not known whether albuterol passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are using albuterol.

How should I take albuterol?

Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.

Albuterol can have long-lasting effects (up to 8 hours or longer). Do not take this medication more often than prescribed.

Do not crush, chew, or break an extended-release tablet. Swallow it whole. Breaking the pill may cause too much of the drug to be released at one time.

Measure liquid medicine with a special dose-measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.

Asthma or bronchospasm is sometimes treated with a combination of drugs. Use all medications as directed by your doctor. Read the medication guide or patient instructions provided with each medication. Do not change your doses or medication schedule without your doctor's advice. You should remain under the care of a doctor while you are using albuterol.

Call your doctor right away if you feel that this medicine is not working as well as usual, or if it makes your condition worse. If it seems like you need to use more of any of your medications in a 24-hour period, talk with your doctor.

Store albuterol tablets at room temperature away from moisture, heat, and light. Keep the bottle tightly closed when not in use.

Do not allow the liquid form of this medicine to freeze.

What happens if I miss a dose?

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. An overdose of albuterol can be fatal.

Overdose symptoms may include severe forms of some of the side effects listed in this medication guide.

What should I avoid while taking albuterol?

Avoid taking diet pills or cold medicine that contains a decongestant (phenylephrine, pseudoephedrine). Taking these medications together with albuterol may cause unpleasant side effects.

Albuterol side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using albuterol and call your doctor at once if you have a serious side effect such as:

  • new bronchospasm or worsening of your asthma symptoms;

  • pounding heartbeats or fluttering in your chest;

  • chest pain, tremor, nervousness;

  • seizure (convulsions);

  • low potassium (confusion, uneven heart rate, extreme thirst, increased urination, leg discomfort, muscle weakness or limp feeling);

  • dangerously high blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, confusion, chest pain, shortness of breath, uneven heartbeats); or

  • severe skin reaction -- fever, sore throat, swelling in your face or tongue, burning in your eyes, skin pain, followed by a red or purple skin rash that spreads (especially in the face or upper body) and causes blistering and peeling.

Less serious side effects may include:

  • dizziness, spinning sensation;

  • headache;

  • sleep problems (insomnia);

  • muscle cramps;

  • dry mouth and throat;

  • unusual taste in your mouth; or

  • nausea.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See also: Side effects (in more detail)

Albuterol dosing information

Usual Adult Dose for Asthma -- Acute:

Intravenous infusion solution:
-Dilute 5 mL of this drug (1000 mcg/mL) in 500 mL of Sodium Chloride Injection, or Sodium Chloride and Dextrose.
-Infusion rates can be started at 5 mcg/min, and can be increased to 10 mcg/min and 20 mcg/min at 15 at 30 minute intervals, if necessary.

Nebulizer inhalation solution:
-2.5 mg three or four times a day by nebulization, over approximately 5 to 15 minutes.

Comments:
-Never inject the IV infusion undiluted. Do not administer in the same infusion with other medications.
-Check the IV infusion for clarity, particulate matter, precipitate, discoloration and leakage prior to administration.
-Discard unused infusion solution 24 hours after preparation.

Uses:
-Relief of severe bronchospasm associated with acute exacerbations of chronic bronchitis and bronchial asthma, and acute attack of bronchospasm
-Treatment of status asthmaticus

Usual Adult Dose for Chronic Obstructive Pulmonary Disease -- Acute:

Intravenous infusion solution:
-Dilute 5 mL of this drug (1000 mcg/mL) in 500 mL of Sodium Chloride Injection, or Sodium Chloride and Dextrose.
-Infusion rates can be started at 5 mcg/min, and can be increased to 10 mcg/min and 20 mcg/min at 15 at 30 minute intervals, if necessary.

Nebulizer inhalation solution:
-2.5 mg three or four times a day by nebulization, over approximately 5 to 15 minutes.

Comments:
-Never inject the IV infusion undiluted. Do not administer in the same infusion with other medications.
-Check the IV infusion for clarity, particulate matter, precipitate, discoloration and leakage prior to administration.
-Discard unused infusion solution 24 hours after preparation.

Uses:
-Relief of severe bronchospasm associated with acute exacerbations of chronic bronchitis and bronchial asthma, and acute attack of bronchospasm
-Treatment of status asthmaticus

Usual Adult Dose for Bronchitis:

Intravenous infusion solution:
-Dilute 5 mL of this drug (1000 mcg/mL) in 500 mL of Sodium Chloride Injection, or Sodium Chloride and Dextrose.
-Infusion rates can be started at 5 mcg/min, and can be increased to 10 mcg/min and 20 mcg/min at 15 at 30 minute intervals, if necessary.

Nebulizer inhalation solution:
-2.5 mg three or four times a day by nebulization, over approximately 5 to 15 minutes.

Comments:
-Never inject the IV infusion undiluted. Do not administer in the same infusion with other medications.
-Check the IV infusion for clarity, particulate matter, precipitate, discoloration and leakage prior to administration.
-Discard unused infusion solution 24 hours after preparation.

Uses:
-Relief of severe bronchospasm associated with acute exacerbations of chronic bronchitis and bronchial asthma, and acute attack of bronchospasm
-Treatment of status asthmaticus

Usual Adult Dose for Bronchospasm Prophylaxis:

Inhalation powder: 2 inhalations (180 mcg) orally 15 to 30 minutes before exercise
Inhalation capsule: 1 inhalation (200 mcg) 15 minutes before exercise

Uses: Prevention of exercise-induced bronchospasm

Usual Adult Dose for Asthma -- Maintenance:

Inhalation powder:
-1 or 2 inhalations (90 to 180 mcg) orally every 4 to 6 hours

Inhalation capsules:
-1 inhalation (200 mcg) orally every 4 to 6 hours
-Maximum dose: 4 inhalations (800 mcg) per day

Nebulizer inhalation solution:
-2.5 mg three or four times a day by nebulization, over approximately 5 to 15 minutes

Oral tablets:
Immediate-release tablets:
-Initial dose: 2 mg or 4 mg orally three or four times a day. Dosage may be cautiously increased stepwise up to a maximum of 8 mg four times a day as tolerated (maximum of 32 mg/day).
-Elderly patients and those sensitive to beta-adrenergic stimulators: The initial dosage should be restricted to 2 mg three or four times a day; dosage may be gradually increased up to 8 mg three or four times a day.

Extended-release tablets:
-Initial dose: 4 mg or 8 mg orally every 12 hours. Dosage may be cautiously increased stepwise under the control of the supervising physician to a maximum 32 mg/day in divided doses (e.g., every 12 hours). In unusual circumstances, such as adults of low body weight, use a starting dosage of 4 mg every 12 hours and progress to 8 mg every 12 hours according to response.

Oral syrup:
-Initial dose: 2 mg or 4 mg orally three or four times a day. Dosage may be cautiously increased stepwise up to a maximum of 8 mg four times a day as tolerated.
-Elderly patients and those sensitive to beta-adrenergic stimulators: The initial dosage should be restricted to 2 mg three or four times a day and individually adjusted thereafter.

Uses:
-Treatment or prevention of bronchospasm due to bronchial asthma, chronic bronchitis and other chronic bronchopulmonary disorders in which bronchospasm is a complicating factor
-Relief of bronchospasm in patients with reversible obstructive airway disease

Usual Adult Dose for Chronic Obstructive Pulmonary Disease -- Maintenance:

Inhalation powder:
-1 or 2 inhalations (90 to 180 mcg) orally every 4 to 6 hours

Inhalation capsules:
-1 inhalation (200 mcg) orally every 4 to 6 hours
-Maximum dose: 4 inhalations (800 mcg) per day

Nebulizer inhalation solution:
-2.5 mg three or four times a day by nebulization, over approximately 5 to 15 minutes

Oral tablets:
Immediate-release tablets:
-Initial dose: 2 mg or 4 mg orally three or four times a day. Dosage may be cautiously increased stepwise up to a maximum of 8 mg four times a day as tolerated (maximum of 32 mg/day).
-Elderly patients and those sensitive to beta-adrenergic stimulators: The initial dosage should be restricted to 2 mg three or four times a day; dosage may be gradually increased up to 8 mg three or four times a day.

Extended-release tablets:
-Initial dose: 4 mg or 8 mg orally every 12 hours. Dosage may be cautiously increased stepwise under the control of the supervising physician to a maximum 32 mg/day in divided doses (e.g., every 12 hours). In unusual circumstances, such as adults of low body weight, use a starting dosage of 4 mg every 12 hours and progress to 8 mg every 12 hours according to response.

Oral syrup:
-Initial dose: 2 mg or 4 mg orally three or four times a day. Dosage may be cautiously increased stepwise up to a maximum of 8 mg four times a day as tolerated.
-Elderly patients and those sensitive to beta-adrenergic stimulators: The initial dosage should be restricted to 2 mg three or four times a day and individually adjusted thereafter.

Uses:
-Treatment or prevention of bronchospasm due to bronchial asthma, chronic bronchitis and other chronic bronchopulmonary disorders in which bronchospasm is a complicating factor
-Relief of bronchospasm in patients with reversible obstructive airway disease

Usual Adult Dose for Reversible Airways Disease -- Maintenance:

Inhalation powder:
-1 or 2 inhalations (90 to 180 mcg) orally every 4 to 6 hours

Inhalation capsules:
-1 inhalation (200 mcg) orally every 4 to 6 hours
-Maximum dose: 4 inhalations (800 mcg) per day

Nebulizer inhalation solution:
-2.5 mg three or four times a day by nebulization, over approximately 5 to 15 minutes

Oral tablets:
Immediate-release tablets:
-Initial dose: 2 mg or 4 mg orally three or four times a day. Dosage may be cautiously increased stepwise up to a maximum of 8 mg four times a day as tolerated (maximum of 32 mg/day).
-Elderly patients and those sensitive to beta-adrenergic stimulators: The initial dosage should be restricted to 2 mg three or four times a day; dosage may be gradually increased up to 8 mg three or four times a day.

Extended-release tablets:
-Initial dose: 4 mg or 8 mg orally every 12 hours. Dosage may be cautiously increased stepwise under the control of the supervising physician to a maximum 32 mg/day in divided doses (e.g., every 12 hours). In unusual circumstances, such as adults of low body weight, use a starting dosage of 4 mg every 12 hours and progress to 8 mg every 12 hours according to response.

Oral syrup:
-Initial dose: 2 mg or 4 mg orally three or four times a day. Dosage may be cautiously increased stepwise up to a maximum of 8 mg four times a day as tolerated.
-Elderly patients and those sensitive to beta-adrenergic stimulators: The initial dosage should be restricted to 2 mg three or four times a day and individually adjusted thereafter.

Uses:
-Treatment or prevention of bronchospasm due to bronchial asthma, chronic bronchitis and other chronic bronchopulmonary disorders in which bronchospasm is a complicating factor
-Relief of bronchospasm in patients with reversible obstructive airway disease

Usual Pediatric Dose for Asthma -- Acute:

Inhalation powder and capsules:
Less than 4 years: Not indicated

4 years or older:
-Inhalation powder: 1 or 2 inhalations (90 or 180 mcg) orally every 4 to 6 hours
-Inhalation capsules:1 inhalation (200 mcg) orally every 4 to 6 hours. The total daily dose should not exceed 4 inhalations (800 mcg).

Nebulizer inhalation solution:
Less than 2 years: Not indicated

2 to 12 years:
-Less than 15 kg: 0.1 to 0.15 mg/kg/dose (one 3 mL unit-dose vial of 1.25 mg or 0.63 mg inhalation solution) by nebulization. The appropriate volume of the 0.5% inhalation solution should be diluted in sterile normal saline solution to a total of 3 mL prior administration. Dosing should not exceed 2.5 mg three to four times daily.
-15 kg or more: 2.5 mg (one 3 mL unit-dose vial of 0.0083%) three or four times a day by nebulization, over approximately 5 to 15 minutes. The 0.5% inhalation solution should be diluted with 2.5 mL of sterile normal saline solution

13 years or older:
-Inhalation solution 0.5% (5 mg/mL): 2.5 mg (0.5 mL diluted with 2.5 mL of sterile saline solution) three or four times a day by nebulization, over approximately 5 to 15 minutes

Use: Relief of bronchospasm in patients with reversible obstructive airway disease and acute attacks of bronchospasm

Usual Pediatric Dose for Chronic Obstructive Pulmonary Disease -- Acute:

Inhalation powder and capsules:
Less than 4 years: Not indicated

4 years or older:
-Inhalation powder: 1 or 2 inhalations (90 or 180 mcg) orally every 4 to 6 hours
-Inhalation capsules:1 inhalation (200 mcg) orally every 4 to 6 hours. The total daily dose should not exceed 4 inhalations (800 mcg).

Nebulizer inhalation solution:
Less than 2 years: Not indicated

2 to 12 years:
-Less than 15 kg: 0.1 to 0.15 mg/kg/dose (one 3 mL unit-dose vial of 1.25 mg or 0.63 mg inhalation solution) by nebulization. The appropriate volume of the 0.5% inhalation solution should be diluted in sterile normal saline solution to a total of 3 mL prior administration. Dosing should not exceed 2.5 mg three to four times daily.
-15 kg or more: 2.5 mg (one 3 mL unit-dose vial of 0.0083%) three or four times a day by nebulization, over approximately 5 to 15 minutes. The 0.5% inhalation solution should be diluted with 2.5 mL of sterile normal saline solution

13 years or older:
-Inhalation solution 0.5% (5 mg/mL): 2.5 mg (0.5 mL diluted with 2.5 mL of sterile saline solution) three or four times a day by nebulization, over approximately 5 to 15 minutes

Use: Relief of bronchospasm in patients with reversible obstructive airway disease and acute attacks of bronchospasm

Usual Pediatric Dose for Bronchitis:

Inhalation powder and capsules:
Less than 4 years: Not indicated

4 years or older:
-Inhalation powder: 1 or 2 inhalations (90 or 180 mcg) orally every 4 to 6 hours
-Inhalation capsules:1 inhalation (200 mcg) orally every 4 to 6 hours. The total daily dose should not exceed 4 inhalations (800 mcg).

Nebulizer inhalation solution:
Less than 2 years: Not indicated

2 to 12 years:
-Less than 15 kg: 0.1 to 0.15 mg/kg/dose (one 3 mL unit-dose vial of 1.25 mg or 0.63 mg inhalation solution) by nebulization. The appropriate volume of the 0.5% inhalation solution should be diluted in sterile normal saline solution to a total of 3 mL prior administration. Dosing should not exceed 2.5 mg three to four times daily.
-15 kg or more: 2.5 mg (one 3 mL unit-dose vial of 0.0083%) three or four times a day by nebulization, over approximately 5 to 15 minutes. The 0.5% inhalation solution should be diluted with 2.5 mL of sterile normal saline solution

13 years or older:
-Inhalation solution 0.5% (5 mg/mL): 2.5 mg (0.5 mL diluted with 2.5 mL of sterile saline solution) three or four times a day by nebulization, over approximately 5 to 15 minutes

Use: Relief of bronchospasm in patients with reversible obstructive airway disease and acute attacks of bronchospasm

Usual Pediatric Dose for Bronchospasm Prophylaxis:

Less than 4 years: Not indicated

4 years or older:
-Inhalation powder: 2 inhalations (180 mcg) orally 15 to 30 minutes before exercise
-Inhalation capsule: 1 inhalation (200 mcg) 15 minutes before exercise

Uses: Prevention of exercise-induced bronchospasm

Usual Pediatric Dose for Asthma -- Maintenance:

Inhalation powder and capsules:
Less than 4 years: Not indicated
4 years or older:
-Inhalation powder: 1 or 2 inhalations (90 or 180 mcg) orally every 4 to 6 hours
-Inhalation capsules:1 inhalation (200 mcg) orally every 4 to 6 hours. The total daily dose should not exceed 4 inhalations (800 mcg).

Nebulizer inhalation solution:
Less than 2 years: Not indicated
2 to 12 years:
-Less than 15 kg: 0.1 to 0.15 mg/kg/dose (one 3 mL unit-dose vial of 1.25 mg or 0.63 mg inhalation solution) by nebulization. The appropriate volume of the 0.5% inhalation solution should be diluted in sterile normal saline solution to a total of 3 mL prior administration. Dosing should not exceed 2.5 mg three to four times daily.
-15 kg or more: 2.5 mg (one 3 mL unit-dose vial of 0.0083%) three or four times a day by nebulization, over approximately 5 to 15 minutes. The 0.5% inhalation solution should be diluted with 2.5 mL of sterile normal saline solution

13 years or older:
-Inhalation solution 0.5% (5 mg/mL): 2.5 mg (0.5 mL diluted with 2.5 mL of sterile saline solution) three or four times a day by nebulization, over approximately 5 to 15 minutes.

Oral Tablets:
Less than 6 years: Not indicated
6 to 12 years:
-Immediate-release tablets: Initial dose: 2 mg orally three or four times a day. Dosage may be cautiously increased stepwise, but not to exceed 24 mg/day (given in divided doses).
-Extended-release tablets: Initial dose: 4 mg orally every 12 hours. Dosage may be cautiously increased stepwise under the control of the supervising physician to a maximum 24 mg/day in divided doses (e.g., every 12 hours).

13 years or older:
-Immediate-release tablets: Initial dose: 2 mg or 4 mg orally three or four times a day. Dosage may be cautiously increased stepwise up to a maximum of 8 mg four times a day as tolerated (maximum of 32 mg/day).
-Extended-release tablets: Initial dose: 4 mg or 8 mg orally every 12 hours. Dosage may be cautiously increased stepwise under the control of the supervising physician to a maximum 32 mg/day in divided doses (e.g., every 12 hours).

Oral syrup:
-Less than 2 years: Not indicated
-2 to 5 years: Initial dose: 0.1 mg/kg (do not exceed 2 mg) orally three times a day. Dosage may be increased stepwise to 0.2 mg/kg three times a day. A maximum dose of 4 mg three times a day should not be exceeded.
-6 to 14 years: Initial dose: 2 mg orally three or four times a day. Dosage may be cautiously increased stepwise, but not exceed 24 mg/day (in divided doses).
-15 years or older: Initial dose: 2 mg or 4 mg orally three or four times a day. Dosage may be cautiously increased stepwise up to a maximum of 8 mg four times a day as tolerated.

Uses: Treatment or prevention of bronchospasm due to bronchial asthma, chronic bronchitis and other chronic bronchopulmonary disorders in which bronchospasm is a complicating factor

Usual Pediatric Dose for Chronic Obstructive Pulmonary Disease -- Maintenance:

Inhalation powder and capsules:
Less than 4 years: Not indicated
4 years or older:
-Inhalation powder: 1 or 2 inhalations (90 or 180 mcg) orally every 4 to 6 hours
-Inhalation capsules:1 inhalation (200 mcg) orally every 4 to 6 hours. The total daily dose should not exceed 4 inhalations (800 mcg).

Nebulizer inhalation solution:
Less than 2 years: Not indicated
2 to 12 years:
-Less than 15 kg: 0.1 to 0.15 mg/kg/dose (one 3 mL unit-dose vial of 1.25 mg or 0.63 mg inhalation solution) by nebulization. The appropriate volume of the 0.5% inhalation solution should be diluted in sterile normal saline solution to a total of 3 mL prior administration. Dosing should not exceed 2.5 mg three to four times daily.
-15 kg or more: 2.5 mg (one 3 mL unit-dose vial of 0.0083%) three or four times a day by nebulization, over approximately 5 to 15 minutes. The 0.5% inhalation solution should be diluted with 2.5 mL of sterile normal saline solution

13 years or older:
-Inhalation solution 0.5% (5 mg/mL): 2.5 mg (0.5 mL diluted with 2.5 mL of sterile saline solution) three or four times a day by nebulization, over approximately 5 to 15 minutes.

Oral Tablets:
Less than 6 years: Not indicated
6 to 12 years:
-Immediate-release tablets: Initial dose: 2 mg orally three or four times a day. Dosage may be cautiously increased stepwise, but not to exceed 24 mg/day (given in divided doses).
-Extended-release tablets: Initial dose: 4 mg orally every 12 hours. Dosage may be cautiously increased stepwise under the control of the supervising physician to a maximum 24 mg/day in divided doses (e.g., every 12 hours).

13 years or older:
-Immediate-release tablets: Initial dose: 2 mg or 4 mg orally three or four times a day. Dosage may be cautiously increased stepwise up to a maximum of 8 mg four times a day as tolerated (maximum of 32 mg/day).
-Extended-release tablets: Initial dose: 4 mg or 8 mg orally every 12 hours. Dosage may be cautiously increased stepwise under the control of the supervising physician to a maximum 32 mg/day in divided doses (e.g., every 12 hours).

Oral syrup:
-Less than 2 years: Not indicated
-2 to 5 years: Initial dose: 0.1 mg/kg (do not exceed 2 mg) orally three times a day. Dosage may be increased stepwise to 0.2 mg/kg three times a day. A maximum dose of 4 mg three times a day should not be exceeded.
-6 to 14 years: Initial dose: 2 mg orally three or four times a day. Dosage may be cautiously increased stepwise, but not exceed 24 mg/day (in divided doses).
-15 years or older: Initial dose: 2 mg or 4 mg orally three or four times a day. Dosage may be cautiously increased stepwise up to a maximum of 8 mg four times a day as tolerated.

Uses: Treatment or prevention of bronchospasm due to bronchial asthma, chronic bronchitis and other chronic bronchopulmonary disorders in which bronchospasm is a complicating factor

Usual Pediatric Dose for Reversible Airways Disease -- Maintenance:

Inhalation powder and capsules:
Less than 4 years: Not indicated
4 years or older:
-Inhalation powder: 1 or 2 inhalations (90 or 180 mcg) orally every 4 to 6 hours
-Inhalation capsules:1 inhalation (200 mcg) orally every 4 to 6 hours. The total daily dose should not exceed 4 inhalations (800 mcg).

Nebulizer inhalation solution:
Less than 2 years: Not indicated
2 to 12 years:
-Less than 15 kg: 0.1 to 0.15 mg/kg/dose (one 3 mL unit-dose vial of 1.25 mg or 0.63 mg inhalation solution) by nebulization. The appropriate volume of the 0.5% inhalation solution should be diluted in sterile normal saline solution to a total of 3 mL prior administration. Dosing should not exceed 2.5 mg three to four times daily.
-15 kg or more: 2.5 mg (one 3 mL unit-dose vial of 0.0083%) three or four times a day by nebulization, over approximately 5 to 15 minutes. The 0.5% inhalation solution should be diluted with 2.5 mL of sterile normal saline solution

13 years or older:
-Inhalation solution 0.5% (5 mg/mL): 2.5 mg (0.5 mL diluted with 2.5 mL of sterile saline solution) three or four times a day by nebulization, over approximately 5 to 15 minutes.

Oral Tablets:
Less than 6 years: Not indicated
6 to 12 years:
-Immediate-release tablets: Initial dose: 2 mg orally three or four times a day. Dosage may be cautiously increased stepwise, but not to exceed 24 mg/day (given in divided doses).
-Extended-release tablets: Initial dose: 4 mg orally every 12 hours. Dosage may be cautiously increased stepwise under the control of the supervising physician to a maximum 24 mg/day in divided doses (e.g., every 12 hours).

13 years or older:
-Immediate-release tablets: Initial dose: 2 mg or 4 mg orally three or four times a day. Dosage may be cautiously increased stepwise up to a maximum of 8 mg four times a day as tolerated (maximum of 32 mg/day).
-Extended-release tablets: Initial dose: 4 mg or 8 mg orally every 12 hours. Dosage may be cautiously increased stepwise under the control of the supervising physician to a maximum 32 mg/day in divided doses (e.g., every 12 hours).

Oral syrup:
-Less than 2 years: Not indicated
-2 to 5 years: Initial dose: 0.1 mg/kg (do not exceed 2 mg) orally three times a day. Dosage may be increased stepwise to 0.2 mg/kg three times a day. A maximum dose of 4 mg three times a day should not be exceeded.
-6 to 14 years: Initial dose: 2 mg orally three or four times a day. Dosage may be cautiously increased stepwise, but not exceed 24 mg/day (in divided doses).
-15 years or older: Initial dose: 2 mg or 4 mg orally three or four times a day. Dosage may be cautiously increased stepwise up to a maximum of 8 mg four times a day as tolerated.

Uses: Treatment or prevention of bronchospasm due to bronchial asthma, chronic bronchitis and other chronic bronchopulmonary disorders in which bronchospasm is a complicating factor

What other drugs will affect albuterol?

Tell your doctor about all other medicines you use, especially:

  • a diuretic (water pill);

  • digoxin (digitalis, Lanoxin);

  • a beta blocker such as atenolol (Tenormin, Tenoretic), carvedilol (Coreg), labetalol (Normodyne, Trandate), metoprolol (Dutoprol, Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal, InnoPran), sotalol (Betapace), and others;

  • an antidepressant such as amitriptyline (Elavil, Etrafon), doxepin (Sinequan), imipramine (Janimine, Tofranil), nortriptyline (Pamelor), and others;

  • a stimulant or ADHD medication such as Adderall, Ritalin, Daytrana, Concerta, and others; or

  • other bronchodilators such as levalbuterol (Xopenex), bitolterol (Tornalate), pirbuterol (Maxair), terbutaline (Brethine, Bricanyl), salmeterol (Serevent), isoetherine (Bronkometer), metaproterenol (Alupent, Metaprel), or isoproterenol (Isuprel Mistometer).

This list is not complete and other drugs may interact with albuterol. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.

Where can I get more information?

  • Your pharmacist can provide more information about albuterol.
  • Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
  • Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2012 Cerner Multum, Inc. Version: 2.02.

Last reviewed: March 08, 2012
Date modified: April 03, 2017

Hide